蔚蓝生物：全资子公司拟4700万元收购艾地盟蔚蓝50%股权

Group 1 - The core point of the article is that Blue Bio (603739) announced its intention to acquire a 50% stake in ADM Singapore's subsidiary, Aidi Meng Blue, for a transaction price of 47 million yuan [1] Group 2 - The acquisition is part of Blue Bio's strategy to expand its business operations and enhance its market position [1] - The transaction reflects Blue Bio's ongoing efforts to strengthen partnerships within the industry [1] - The deal is expected to contribute positively to Blue Bio's financial performance in the future [1]